There have been 50 recent insider transactions recorded for Biohaven Ltd. (BHVN), including 39 buys and 10 sells. Total insider buying was valued at $73.9M and total insider selling at $113.71K.
Notable insiders with recent activity include Mehta Kishan, Gentile Kimberly, Coric Vlad. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — BHVN
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-17 |
Mehta Kishan |
Director |
Gift (Given) |
17,342 |
- |
- |
5,320 |
| 2026-02-27 |
Gentile Kimberly |
SVP, Clinical Operations |
RSU Award |
175,000 |
$11.52 |
$2.02M |
175,000 |
| 2026-02-27 |
Coric Vlad |
Chief Executive Officer |
RSU Award |
550,000 |
$11.52 |
$6.34M |
550,000 |
| 2026-02-27 |
Car Bruce |
Chief Scientific Officer |
RSU Award |
175,000 |
$11.52 |
$2.02M |
175,000 |
| 2026-02-27 |
Clark George C. |
VP, Chief Accounting Officer |
RSU Award |
50,000 |
$11.52 |
$576K |
50,000 |
| 2026-02-27 |
Buten Matthew |
Chief Financial Officer |
RSU Award |
175,000 |
$11.52 |
$2.02M |
175,000 |
| 2026-01-05 |
Gentile Kimberly |
SVP, Clinical Operations |
Option Exercise (Sell) |
3,750 |
- |
- |
7,500 |
| 2026-01-05 |
Coric Vlad |
Chief Executive Officer |
Option Exercise (Sell) |
14,250 |
- |
- |
28,500 |
| 2026-01-05 |
Car Bruce |
Chief Scientific Officer |
Tax Withholding of RSU |
2,381 |
$9.93 |
$23.64K |
7,715 |
| 2026-01-05 |
Clark George C. |
VP, Chief Accounting Officer |
Option Exercise (Sell) |
2,500 |
- |
- |
5,000 |
| 2026-01-05 |
Buten Matthew |
Chief Financial Officer |
Option Exercise (Sell) |
4,250 |
- |
- |
8,500 |
| 2025-11-17 |
Clark George C. |
VP, Chief Accounting Officer |
Informative Buy |
17,000 |
$8.52 |
$144.77K |
20,000 |
| 2025-11-13 |
Childs John W |
Director |
Informative Buy |
3,333,333 |
$7.50 |
$25M |
5,653,904 |
| 2025-11-13 |
Bailey Gregory |
Director |
Informative Buy |
400,000 |
$7.50 |
$3M |
2,020,071 |
| 2025-11-13 |
Coric Vlad |
Chief Executive Officer |
Informative Buy |
333,333 |
$7.50 |
$2.5M |
740,546 |
| 2025-05-05 |
Childs John W |
Director |
RSU Award |
31,716 |
$22.62 |
$717.42K |
31,716 |
| 2025-05-05 |
Gregory Julia P |
Director |
RSU Award |
31,716 |
$22.62 |
$717.42K |
31,716 |
| 2025-05-05 |
Hugin Robert J |
Director |
RSU Award |
31,716 |
$22.62 |
$717.42K |
31,716 |
| 2025-05-05 |
Bailey Gregory |
Director |
RSU Award |
31,716 |
$22.62 |
$717.42K |
31,716 |
| 2025-05-05 |
Heffernan Michael Thomas |
Director |
RSU Award |
31,716 |
$22.62 |
$717.42K |
31,716 |
| 2025-05-05 |
Mehta Kishan |
Director |
RSU Award |
31,716 |
$22.62 |
$717.42K |
31,716 |
| 2025-05-05 |
Antonijevic Irina |
Director |
RSU Award |
31,716 |
$22.62 |
$717.42K |
31,716 |
| 2025-03-04 |
Childs John W |
Director |
Informative Buy |
3,400 |
$30.73 |
$104.47K |
24,452 |
| 2025-03-04 |
Childs John W |
Director |
Informative Buy |
28,400 |
$30.43 |
$864.12K |
2,323,971 |
| 2025-01-05 |
Gentile Kimberly |
SVP, Clinical Operations |
Option Exercise (Sell) |
3,750 |
- |
- |
11,250 |
| 2025-01-05 |
Coric Vlad |
Chief Executive Officer |
Option Exercise (Sell) |
14,250 |
- |
- |
42,750 |
| 2025-01-05 |
Car Bruce |
Chief Scientific Officer |
Tax Withholding of RSU |
2,331 |
$38.64 |
$90.07K |
4,802 |
| 2025-01-05 |
Clark George C. |
VP, Chief Accounting Officer |
Option Exercise (Sell) |
2,500 |
- |
- |
7,500 |
| 2025-01-05 |
Buten Matthew |
Chief Financial Officer |
Option Exercise (Sell) |
4,250 |
- |
- |
12,750 |
| 2024-12-30 |
Childs John W |
Director |
Informative Buy |
29,000 |
$35.94 |
$1.04M |
2,368,741 |
| 2024-10-02 |
Childs John W |
Director |
Informative Buy |
21,052 |
$47.50 |
$999.97K |
21,052 |
| 2024-10-02 |
Coric Vlad |
Chief Executive Officer |
Informative Buy |
21,052 |
$47.50 |
$999.97K |
861,942 |
| 2024-09-24 |
Bailey Gregory |
Director |
Informative Buy |
5,000 |
$44.19 |
$220.97K |
1,620,071 |
| 2024-07-18 |
Childs John W |
Director |
Informative Buy |
28,400 |
$35.67 |
$1.01M |
2,339,741 |
| 2024-06-17 |
Car Bruce |
Chief Scientific Officer |
Informative Buy |
30,000 |
$33.58 |
$1.01M |
30,000 |
| 2024-05-30 |
Childs John W |
Director |
Informative Buy |
28,000 |
$35.58 |
$996.24K |
2,311,341 |
| 2024-05-13 |
Childs John W |
Director |
Informative Buy |
28,500 |
$35.17 |
$1M |
2,283,341 |
| 2024-05-13 |
Bailey Gregory |
Director |
Informative Buy |
15,000 |
$34.19 |
$512.88K |
1,615,071 |
| 2024-04-30 |
Childs John W |
Director |
RSU Award |
16,592 |
$38.80 |
$643.77K |
16,592 |
| 2024-04-30 |
Gregory Julia P |
Director |
RSU Award |
16,592 |
$38.80 |
$643.77K |
16,592 |
| 2024-04-30 |
Hugin Robert J |
Director |
RSU Award |
16,592 |
$38.80 |
$643.77K |
16,592 |
| 2024-04-30 |
Bailey Gregory |
Director |
RSU Award |
16,592 |
$38.80 |
$643.77K |
16,592 |
| 2024-04-30 |
Heffernan Michael Thomas |
Director |
RSU Award |
16,592 |
$38.80 |
$643.77K |
16,592 |
| 2024-04-30 |
Mehta Kishan |
Director |
RSU Award |
16,592 |
$38.80 |
$643.77K |
16,592 |
| 2024-04-30 |
Antonijevic Irina |
Director |
RSU Award |
16,592 |
$38.80 |
$643.77K |
16,592 |
| 2024-04-24 |
Bailey Gregory |
Director |
Informative Buy |
25,503 |
$39.18 |
$999.17K |
1,600,071 |
| 2024-04-22 |
Childs John W |
Director |
Informative Buy |
73,170 |
$41.00 |
$3M |
73,170 |
| 2024-04-22 |
Childs John W |
Director |
Informative Buy |
24,391 |
$41.00 |
$1M |
24,391 |
| 2024-04-22 |
Bailey Gregory |
Director |
Informative Buy |
48,780 |
$41.00 |
$2M |
1,574,568 |
| 2024-04-22 |
Coric Vlad |
Chief Executive Officer |
Informative Buy |
121,951 |
$41.00 |
$5M |
1,788,417 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
